Springer Nature OAopen access
Cannabinoid CB_2 receptor drives trastuzumab resistance and predicts durable anti-HER2 response
Medicine & Public Health, Medicine/Public Health, general, Internal Medicine, Cell Biology, Human Genetics, Oncology
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 299084
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.